Spedali Civili

Running trials

• Active, not recruiting

  First Line Treatment With Olaparib in Combination With Bevacizumab in HRD Positive Patients

  NCT06121401· Phase 4· Source

• Recruiting

  Metabolic Exercise Test Data Combined with Cardiac and Kidney Indexes (MECKI) Score Evolution: Identification of Cardiovascular Risk in Patients with Heart Failure

  NCT06884631· Source

• Not yet recruiting

  Hepatocarcinoma Recurrence on the Liver Study - Part2

  NCT04053231· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Heart failure1 recruiting
• Liver and biliary tract cancer1 recruiting

Researchers

No researcher is linked here yet.

Closed trials

• Completed

  Platinum-based Chemotherapy With Atezolizumab and Niraparib in Patients With Recurrent Ovarian Cancer

  NCT03598270· Phase 3· Source

• Completed

  New Combination of Chemoimmunotherapy for Systemic B-cell Lymphoma With Central Nervous System Involvement

  NCT02329080· Phase 2· Source

• Completed

  Ro Plus CHOEP as First Line Treatment Before HSCT in Young Patients With Nodal Peripheral T-cell Lymphomas

  NCT02223208· Phase 1/2· Source

• Completed

  A Phase III Multicenter, Randomized Study Comparing RIT Vs ASCT in Patients With Relapsed/Refractory (FL)

  NCT01827605· Phase 3· Source